Heparin induced thrombocytopenia in relation to SARS-CoV-2 infection and ABO blood group

Joel G Ray; Theodore E Warkentin; Alison L Park

doi:10.1016/j.thromres.2021.09.008

Heparin induced thrombocytopenia in relation to SARS-CoV-2 infection and ABO blood group

Thromb Res. 2021 Nov:207:62-65. doi: 10.1016/j.thromres.2021.09.008. Epub 2021 Sep 17.

Authors

Joel G Ray¹, Theodore E Warkentin², Alison L Park³

Affiliations

¹ Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada; Department of Obstetrics and Gynaecology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada; ICES, Toronto, Ontario, Canada. Electronic address: rayj@smh.ca.
² Department of Pathology and Molecular Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
³ ICES, Toronto, Ontario, Canada.

No abstract available

Keywords: ABO blood group; Heparininduced thrombocytopenia (HIT); SARS-CoV-2; Vaccine-induced immune thrombotic thrombocytopenia; Venous thromboembolism.

Publication types

Letter